Alturas Analytics Logo
BIOANALYSIS ZONE PANEL DISCUSSION
As a highly powerful tool that routinely aids in the identification and quantification of drug metabolites and candidates, as well as their interactions, mass spectrometry provides several advantages to small molecule bioanalysis, which we will explore in this panel discussion.

December 9, 2021
8:00 AM PST
BIOANALYSIS ZONE SPOTLIGHT
Small Molecule Analysis Using MS

This feature discusses:

  • Trending analytical techniques for MS in small molecule analysis
  • Key challenges in utilizing MS for small molecules
  • The role of bioanalytical outsourcing in small molecule analysis using MS
  • The future of MS in small molecule analysis
RECENT FEATURES

Visit the Alturas Analytics website for a full listing of presentations and publications.
Ask the Experts: Oligonucleotide Analysis and Therapeutics

Featured on Bioanalysis Zone
Analysis of Small Molecule Drug Candidates: an Interview with Katherine Yahvah

Featured on Bioanalysis Zone
Development of Validated LC-MS Methods Using Surrogate Matrices for the Quantification of Biomarkers of Clinically Significant Drug-Drug Interactions 

Presented at the 69th ASMS Conference
Developing a Rugged Chiral Assay for the Biomarker 2-Hydroxyglutaric Acid for Use in Routine Clinical Analysis of Plasma Samples from Oncology Studies
Presented at the Applied Pharmaceutical Analysis 2021 

Take advantage of our growing library of resources.
About Alturas Analytics, Inc.
Alturas Analytics is a GLP compliant bioanalytical CRO specializing in MS/MS solutions supporting early discovery through late phase clinical trials. In addition to providing PK support services to pharmaceutical companies worldwide, Alturas maintains an intensive research effort of applying new technologies leading to scientific advancement for high-throughput bioanalysis. The success of Alturas is built on developing long term collaborations with clients by delivering personalized, bioanalytical results on time with the highest level of integrity.


Contact Us
To set up a meeting time to discuss the ways our expert scientists address critical factors inherent to assay development, contact Lori Payne, [email protected], or John Ingram, [email protected].